In COPD, an increase in soluble pro-inflammatory molecules systemically tilts the balance of the osteoprotegerin (OPG)/RANKL axis toward RANKL, which propels the development of osteoporosis [15,16]. Here, TNFSF11 is linked to chronic obstructive pulmonary disease.